Lennox Gastaut Syndrome Clinical Trials

Lennox Gastaut Syndrome Clinical Trials

Lennox Gastaut Syndrome research studies recruiting patients need your help. Receive premium care & cutting edge treatments by enrolling in clinical trials today.

Lennox Gastaut Syndrome Clinical Trials

Here are the 6 most popular medical studies for

Popular filter options for trials

Lennox Gastaut Syndrome Clinical Trials

View 66 Lennox Gastaut Syndrome medical studies.

Temporal Lobe Epilepsy Clinical Trials

View 66 Temporal Lobe Epilepsy medical studies.

Phase 3 Lennox Gastaut Clinical Trials

View 99 phase 3 lennox gastaut medical studies.

Lennox Gastaut Clinical Trials With No Placebo

View 99 lennox gastaut medical studies that do not have a placebo group.

View More Trials

See another 78 many medical studies focused on .

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to

What are the top hospitals conducting undefined research?

When it comes to cutting-edge clinical trials in the field of undefined, several hospitals are leading the way. The renowned Mayo Clinic in Rochester is at the forefront, currently conducting an impressive 14 active trials focused on this condition. Although they have yet to conduct any previous undefined trials, their commitment to research and innovation promises exciting developments in the future. In Bethesda, Maryland, the Mid-Atlantic Epilepsy, Maryland, the Mid-Atlantic Epilepsy and Sleep Center has also dedicated itself to advancing knowledge in this area with nine ongoing clinical trials. Similarly, the Northeast Regional Epilepsy Group in Hackensack is actively involved in eight undefined trials, each contributing valuable insights.

On another coast altogether lies Seattle Children's Hospital, where experts are immersed in seven active undefined trials aimed at improving our understanding of this complex condition that affects so many lives. Meanwhile,the Children's Hospital of Philadelphia joins these esteemed institutions with an equal number of ongoing undefined studies and a shared mission to push boundaries for better treatments.

These hospitals represent just a fraction of the efforts being made across various locations to unravel the mysteries surroundingundefined.. Through rigorous research and collaboration between medical professionals and patients alike,various strategies can be implementedto address,, manage or even prevent complications associated with such conditions . With every new trial conducted by these dedicated institutions,the potential for transformative breakthroughs grows closer,and hope shines brighter for those affected byundefinedacross different communities nationwide

Which are the best cities for undefined clinical trials?

When it comes to undefined clinical trials, several cities are at the forefront of research and innovation. New York, with its 27 active trials, explores treatments like Lorcaserin, Soticlestat, and ZX008 (Fenfluramine Hydrochloride). Rochester in Minnesota follows closely behind with 22 ongoing studies focused on Ganaxalone (GNX), LP352, and ZX008 (Fenfluramine Hydrochloride). Additionally, Miami in Florida and Philadelphia in Pennsylvanian Minnesoon. New York, with its 27 active trials, explores treatments like Lorcaserin, Soticlestat, and ZX008 (Fenfluramine Hydrochloride). Rochester in Minnesota follows closely behind with 22 ongoing studies focused on Ganaxalone (GNX), LP352, and ZX008 (Fenfluramine Hydrochloride). Additionally, Miami in Florida and Philadelphia in Pennsylvania both offer promising opportunities for clinical trials with 21 active studies each. These cities provide individuals seeking cutting-edge medical advancements access to a range of innovative therapies that can potentially transform lives.

Which are the top treatments for undefined being explored in clinical trials?

Clinical trials are actively investigating several promising treatments for an undefined condition. Leading the pack is daratumumab, with an impressive track record of 6 active trials and a total of 134 breast cancer trials since its introduction in 2012. Another noteworthy contender is belantamab mafodotin, currently being explored in 4 ongoing clinical trials with a previous involvement in 26 breast cancer studies since its debut in 2018. Lastly, lenalidomidet cancer studies since its debut in 2018. Lastly, lenalidomide continues to prove its worth with three active clinical trials and an extensive history of participation in 280 diverse trial settings dating back to 2003. These advancements bring renewed hope as researchers strive to unravel new treatment possibilities for this yet-to-be-defined condition.

What are the most recent clinical trials for undefined?

Recent clinical trials have brought forth promising advancements in the field of undefined conditions, offering potential breakthroughs for patients seeking effective treatments. One such trial investigated the use of fenfluramine as a treatment option, showing positive results during its Phase 2 stage. Additionally, Magnetic Resonance Imaging-guided Focused Ultrasound Ablation (MRgFUSA) has shown promise in early-stage testing for undefined conditions. Another study explored the effectiveness of methylphenidate during its Phase 4 trial, providing valuable insights into potential therapeutic benefits. Furthermore, XEN1101 displayed promising outcomes in Phase 3 trials and offers hope for alleviating symptoms associated with undefined conditions. Lastly, Diazepam showcased encouraging results across both Phase 1 and Phase 2 trials conducted earlier this year. As these recent clinical trials continue to unfold and progress towards completion, they hold great potential to enhance the quality of life for individuals living with undefined conditions.

What undefined clinical trials were recently completed?

Recently completed clinical trials in an unspecified field have made significant strides towards advancing medical research. These trials, which concluded within the last year, have contributed valuable insights and potential breakthroughs that hold promise for future treatments. The completion of these trials underscores the dedication and innovation of researchers who are committed to pushing the boundaries of scientific knowledge and improving patient outcomes.